European heart journal. Cardiovascular pharmacotherapy, cilt.8, ss.372-382, 2022 (SCI-Expanded)
Aims The safety of digoxin therapy in atrial fibrillation (AF) remains ill-defined. We aimed to evaluate the effects of digoxin over beta-blocker therapy in AF.